-
WHO Honors Henrietta Lacks, Whose Cells Helped in Vaccine Research
“She never knew she was a participant, and that’s the tragedy here, but her contribution to the fields of science and biology is without question and really, unrivaled.” Dr. Ugo Iroku talks about Henrietta Lacks, a Black cervical cancer patient whose cell samples were used in decades of biological research, including for the COVID-19 vaccines. Lacks’ cells were taken without...
-
Unvaccinated COVID-19 Survivors Twice as Likely to Get Reinfected, Study Shows
Even people who have recovered from COVID-19 are urged to get vaccinated, and a new study shows survivors who ignored that advice had twice the risk of getting reinfected.
-
How TikTok Is Helping Debunk Myths and Reduce Fears About the COVID-19 Vaccine
Dances and duets are not the only videos trending on TikTok. NBC News youth and internet culture reporter Kalhan Rosenblatt discusses how young people are turning to the video app for information about the COVID-19 vaccines, and gives us a firsthand look at a TikToker’s experience as a vaccine trial participant.
-
The Science Behind Pfizer and Moderna's mRNA COVID-19 Vaccines and How They Work
Two mRNA vaccines from Pfizer and Moderna are nearing final approval. But how do they work? Michael Teng, an associate professor at the University of South Florida’s College of Medicine, joined LX News to explain the role mRNA plays in making these vaccines work and why they should be trusted.
-
The U.S. Won't Join the COVAX Facility to Develop a Global Covid Vaccine. Here's Why That's a Bad Idea
The COVAX facility is a global effort to find, develop and distribute a safe, effective coronavirus vaccine to every country in the world. But the U.S. has declined to participate due to President Trump’s lack of confidence in the World Health Organization. But can an America-first strategy for vaccine development work? The New York Times takes a closer look....